JAMA
Original Investigation
April 24, 2024
Cynthia Gyamfi-Bannerman, MD, MS; Rebecca G.ÌýClifton, PhD; Alan T. N.ÌýTita, MD, PhD; Sean C.ÌýBlackwell, MD; Monica Longo, MD, PhD; Jessica A.Ìýde Voest, PhD; T. Michael O’Shea, MD, MPH; Sabine Z.ÌýBousleiman, MSN, MSPH; Felecia Ortiz, RN, BSN; Dwight J.ÌýRouse, MD; Torri D.ÌýMetz, MD, MS; George R.ÌýSaade, MD; Kara M.ÌýRood, MD; Kent D.ÌýHeyborne, MD; John M.ÌýThorp Jr, MD; Geeta K.ÌýSwamy, MD; William A.ÌýGrobman, MD, MBA; Kelly S.ÌýGibson, MD; Yasser Y.ÌýEl-Sayed, MD; George A.ÌýMacones, MD, MSCE; Eunice Kennedy Shriver Maternal-Fetal Medicine Units Network
is active quiz
online first
JAMA. 2024; 10.1001/jama.2024.4303
This prospective follow-up study of a randomized clinical trial evaluates whether antenatal corticosteroids administered to birthing parents at risk of late preterm delivery were associated with adverse neurodevelopmental effects on their offspring.